Join Foley, CollectiveMinds, HSBC Innovation Banking, and Magnet in Silicon Valley for Capital Connect, a high‑value look at what early‑stage life science companies need to move from Seed to Series A in an increasingly diligence‑driven market.
Hear insights from venture investors, repeat founder‑CEOs, seasoned biotech operators, and senior intellectual property legal experts. They’ll dive into investor expectations, smart milestone design, intellectual property and legal essentials, early team building, operational readiness, and real‑world lessons from recent fundraises. This discussion will offer practical guidance and meaningful connections for Seed and early Series A founders, CEOs, investors, and advisors navigating an increasingly rigorous market.
Cosponsors



Speakers






